Accellix
Latest round
- Series D
Last raised
- Jun 2020
Total raised
- $9.5M
Investors
- 2
About Accellix
Accellix, Inc.Accellix, Inc. was founded in 2007 and is headquartered in San Jose, US. The company operates in the cell therapy sector, providing advanced solutions for quality control during manufacturing.00 mn.Accellix offers an automated cell phenotyping platform designed for the GMP manufacturing environment. Its flagship product, the Accellix Instrument, combines automated sample preparation, flow cytometry, and extensive data analysis into a compact benchtop system. Utilizing a microfluidic cartridge and unitized dried reagents, the platform ensures reproducibility and accuracy while reducing manual handling.Accellix generates revenue through B2B transactions with biotechnology and pharmaceutical companies focused on cell and gene therapy.00 mn in December 2021, Accellix plans to accelerate its commercial and development efforts. The company aims to expand its product offerings, although specific upcoming launches have not been disclosed. Additionally, Accellix is targeting expansion into new geographic markets to broaden its reach in the cell therapy sector, with strategic plans set to be implemented in the coming years.
Who invested in Accellix
2 investors across 1 round
See all investors in Accellix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Jun 11, 2020
Amount
$9.5M
Investors
Questions about Accellix
Who invested in Accellix?
Accellix has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Accellix raised?
Accellix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Accellix last raise money?
Accellix's most recent round on record is a Series D, in Jun 2020.
What does Accellix do?
Accellix is a biotechnology company.
Where is Accellix headquartered?
Accellix is headquartered in San Jose, US.
Which VCs invest in companies like Accellix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Accellix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Accellix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.